These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21603479)

  • 1. New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs.
    Goldman S; Galarneau D; Friedman R
    Ochsner J; 2007; 7(1):37-9. PubMed ID: 21603479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
    Markel H; Lee A; Holmes RD; Domino EF
    J Pediatr; 1994 Nov; 125(5 Pt 1):817-9. PubMed ID: 7965440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flashback to the 1960s: LSD in the treatment of autism.
    Sigafoos J; Green VA; Edrisinha C; Lancioni GE
    Dev Neurorehabil; 2007; 10(1):75-81. PubMed ID: 17608329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flashback: psychiatric experimentation with LSD in historical perspective.
    Dyck E
    Can J Psychiatry; 2005 Jun; 50(7):381-8. PubMed ID: 16086535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD).
    Kawasaki A; Purvin V
    Arch Ophthalmol; 1996 Jan; 114(1):47-50. PubMed ID: 8540850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling.
    Buchborn T; Schröder H; Höllt V; Grecksch G
    J Psychopharmacol; 2014 Jun; 28(6):545-52. PubMed ID: 24785760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual phenomenology of the LSD flashback.
    Abraham HD
    Arch Gen Psychiatry; 1983 Aug; 40(8):884-9. PubMed ID: 6135405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium.
    Bonson KR; Murphy DL
    Behav Brain Res; 1996; 73(1-2):229-33. PubMed ID: 8788508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert⁺/⁻) mice.
    Kyzar EJ; Stewart AM; Kalueff AV
    Behav Brain Res; 2016 Jan; 296():47-52. PubMed ID: 26340513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
    Whitaker PM; Seeman P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review.
    Edinoff AN; Akuly HA; Hanna TA; Ochoa CO; Patti SJ; Ghaffar YA; Kaye AD; Viswanath O; Urits I; Boyer AG; Cornett EM; Kaye AM
    Neurol Int; 2021 Aug; 13(3):387-401. PubMed ID: 34449705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.